Status:

UNKNOWN

Upper Limb Telerehabilitation With Virtual Reality in Multiple Sclerosis

Lead Sponsor:

University of Cagliari

Collaborating Sponsors:

Azienda Sanitaria Locale di Cagliari

Tel Aviv University

Conditions:

Multiple Sclerosis

Eligibility:

All Genders

25-60 years

Phase:

NA

Brief Summary

This study aims to investigate the effectiveness of a home-based telerehabilitation program specifically designed for upper limbs, based on Virtual Reality (VR) in individuals affected by Multiple Scl...

Detailed Description

Approximately 60% of people with multiple sclerosis (pwMS) suffer from upper limb dysfunction. The primary goal of this study is to implement a single-blind, randomized control trial (RCT) designed to...

Eligibility Criteria

Inclusion

  • diagnosis of MS according to the revised McDonald Criteria 2017;
  • aged 25-60 years old;
  • an Expanded Disability Status Scale score ≥6;
  • an ability to understand and execute simple instructions;
  • a cut-off score of \>0.5 pegs/s(=18s) on the NHPT (selected due to its high discriminative and predictive ability in distinguishing ADL independence in pwMS).

Exclusion

  • orthopedic and other neurological disorders affecting upper limb movements (e.g., epileptic seizures);
  • contra-indication to physical activity (e.g., heart failure, severe osteoporosis);
  • moderate or severe cognitive impairments as indicated by the Mini-Mental State Examination score \<21;
  • pregnancy (self-reported);
  • severe uncorrected visual deficits;
  • MS clinical relapse or treatment with corticosteroid therapy within 90 days prior to enrollment;
  • started or stopped a disease-modifying therapy for MS within 90 days prior to enrollment;
  • patients who received a course of physical or occupational therapy (home, outpatient or inpatient) within the past 30 days;
  • other treatments that could influence the effects of the interventions

Key Trial Info

Start Date :

December 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2022

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT04032431

Start Date

December 1 2020

End Date

September 1 2022

Last Update

March 24 2020

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

The Multiple Sclerosis Center, Sheba Medical Center

Tel Litwinsky, Israel

2

Laboratorio di Biomeccanica ed Ergonomia industriale - Università degli Studi di Cagliari

Monserrato, Cagliari, Italy, 09042